Colorectal mucus binds DC-SIGN and inhibits HIV-1 trans-infection of CD4+ T-lymphocytes

PloS One
Martijn J StaxWilliam A Paxton

Abstract

Bodily secretions, including breast milk and semen, contain factors that modulate HIV-1 infection. Since anal intercourse caries one of the highest risks for HIV-1 transmission, our aim was to determine whether colorectal mucus (CM) also contains factors interfering with HIV-1 infection and replication. CM from a number of individuals was collected and tested for the capacity to bind DC-SIGN and inhibit HIV-1 cis- or trans-infection of CD4+ T-lymphocytes. To this end, a DC-SIGN binding ELISA, a gp140 trimer competition ELISA and HIV-1 capture/ transfer assays were utilized. Subsequently we aimed to identify the DC-SIGN binding component through biochemical characterization and mass spectrometry analysis. CM was shown to bind DC-SIGN and competes with HIV-1 gp140 trimer for binding. Pre-incubation of Raji-DC-SIGN cells or immature dendritic cells (iDCs) with CM potently inhibits DC-SIGN mediated trans-infection of CD4+ T-lymphocytes with CCR5 and CXCR4 using HIV-1 strains, while no effect on direct infection is observed. Preliminary biochemical characterization demonstrates that the component seems to be large (>100kDa), heat and proteinase K resistant, binds in a α1-3 mannose independent manner and is highly variant between ind...Continue Reading

References

Aug 28, 2003·JAMA : the Journal of the American Medical Association·Ted Rosen
Sep 2, 2003·Nature Reviews. Immunology·Yvette van Kooyk, Teunis B H Geijtenbeek
Jun 15, 2004·Nature Structural & Molecular Biology·Yuan GuoKurt Drickamer
Oct 22, 2005·The Journal of Clinical Investigation·Marloes A NaardingWilliam A Paxton
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thijs van MontfortWilliam A Paxton
Dec 18, 2007·Cell·Jan MünchFrank Kirchhoff
May 13, 2008·Nature Reviews. Immunology·Florian Hladik, M Juliana McElrath
Mar 5, 2009·Antimicrobial Agents and Chemotherapy·Carolina HerreraRobin J Shattock
Jun 3, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Julie A MartelliniAlexander M Cole
Oct 28, 2009·The Journal of Experimental Medicine·Ana CeballosJorge Geffner
Feb 10, 2011·Journal of Translational Medicine·Jean-Charles GrivelLeonid B Margolis
Mar 3, 2011·The American Journal of Tropical Medicine and Hygiene·Jennifer A DownsDaniel W Fitzgerald
Oct 21, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Juan SabatteSebastian Amigorena

❮ Previous
Next ❯

Methods Mentioned

BETA
lavage
ELISA
FCS
Assay
FACS
flow cytometry
pull-down
immunoprecipitation
pull down
the pull

Software Mentioned

Bruker Compass DataAnalysis
Mascot

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.